Staphylococcus aureus adenosine inhibits sPLA2-IIA-mediated host killing in the airways

Journal of Immunology

Volumn 194, Issue 11, 2015, Pages 5312-5319

  Pernet, Erwan ^a,b   Brunet, Jérémy ^a,c   Guillemot, Laurent ^a   Chignard, Michel ^a   Touqui, Lhousseine ^a   Wu, Yongzheng ^a  

^a INSTITUT PASTEUR   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDOGLYCAN; SECRETORY PHOSPHOLIPASE A2; SECRETORY PHOSPHOLIPASE A2 TYPE II; UNCLASSIFIED DRUG; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; IMIDAZOLE DERIVATIVE; PHOSPHOLIPASE A2 GROUP II; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; GUINEA PIG; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CHO CELL LINE; CRICETULUS; GENETICS; HAMSTER; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG LAVAGE; METABOLISM; MICROBIOLOGY; PHOSPHORYLATION;

ADENOSINE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GROUP II PHOSPHOLIPASES A2; GUINEA PIGS; HOST-PATHOGEN INTERACTIONS; IMIDAZOLES; MACROPHAGES, ALVEOLAR; MALE; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; PHOSPHORYLATION; PYRIDINES; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84929649806     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402665     Document Type: Article

References (49)

1. Gonzalez, B. E., K. G. Hulten, M. K. Dishop, L. B. Lamberth, W. A. Hammerman, E. O. Mason, Jr., and S. L. Kaplan. 2005. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin. Infect. Dis. 41: 583-590.
2. Rubinstein, E., M. H. Kollef, and D. Nathwani. 2008. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 46(Suppl 5): S378-S385.
3. Defres, S., C. Marwick, and D. Nathwani. 2009. MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia. Eur. Respir. J. 34: 1470-1476.
4. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165: 5392-5396.
5. Bubeck Wardenburg, J., W. A. Williams, and D. Missiakas. 2006. Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins. Proc. Natl. Acad. Sci. USA 103: 13831-13836.
6. Girardin, S. E., I. G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G. Thomas, D. J. Philpott, and P. J. Sansonetti. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278: 8869-8872.
7. Hruz, P., A. S. Zinkernagel, G. Jenikova, G. J. Botwin, J. P. Hugot, M. Karin, V. Nizet, and L. Eckmann. 2009. NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation. Proc. Natl. Acad. Sci. USA 106: 12873-12878.
8. Kobayashi, K. S., M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, G. Nuñez, and R. A. Flavell. 2005. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731-734.
9. Volz, T., M. Nega, J. Buschmann, S. Kaesler, E. Guenova, A. Peschel, M. Röcken, F. Götz, and T. Biedermann. 2010. Natural Staphylococcus aureusderived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J. 24: 4089-4102.
10. Voss, E., J. Wehkamp, K. Wehkamp, E. F. Stange, J. M. Schröder, and J. Harder. 2006. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J. Biol. Chem. 281: 2005-2011.
11. Wu, Y., B. Raymond, P. L. Goossens, E. Njamkepo, N. Guiso, M. Paya, and L. Touqui. 2010. Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host. Biochimie 92: 583-587.
12. Grönroos, J. O., V. J. O. Laine, and T. J. Nevalainen. 2002. Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections. J. Infect. Dis. 185: 1767-1772.
13. Gimenez, A. P., Y.-Z. Wu, M. Paya, C. Delclaux, L. Touqui, and P. L. Goossens. 2004. High bactericidal efficiency of type iia phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin. J. Immunol. 173: 521-530.
14. Koduri, R. S., J. O. Grönroos, V. J. O. Laine, C. Le Calvez, G. Lambeau, T. J. Nevalainen, and M. H. Gelb. 2002. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). J. Biol. Chem. 277: 5849-5857.
15. Qu, X. D., and R. I. Lehrer. 1998. Secretory phospholipase A2 is the principal bactericide for staphylococci and other Gram-positive bacteria in human tears. Infect. Immun. 66: 2791-2797.
16. Movert, E., Y. Wu, G. Lambeau, F. Kahn, L. Touqui, and T. Areschoug. 2013. Secreted group IIA phospholipase A2 protects humans against the group B streptococcus: experimental and clinical evidence. J. Infect. Dis. 208: 2025-2035.
17. Laine, V. J., D. S. Grass, and T. J. Nevalainen. 1999. Protection by group II phospholipase A2 against Staphylococcus aureus. J. Immunol. 162: 7402-7408.
18. Pernet, E., L. Guillemot, P. R. Burgel, C. Martin, G. Lambeau, I. Sermet-Gaudelus, D. Sands, D. Leduc, P. C. Morand, L. Jeammet, et al. 2014. Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity. Nat. Commun. 5: 5105.
19. Piris-Gimenez, A., M. Paya, G. Lambeau, M. Chignard, M. Mock, L. Touqui, and P. L. Goossens. 2005. In vivo protective role of human group IIa phospholipase A2 against experimental anthrax. J. Immunol. 175: 6786-6791.
20. Foster, T. J. 2005. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3: 948-958.
21. Baxt, L. A., A. C. Garza-Mayers, and M. B. Goldberg. 2013. Bacterial subversion of host innate immune pathways. Science 340: 697-701.
22. McCarthy, A. J., and J. A. Lindsay. 2010. Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions. BMC Microbiol. 10: 173.
23. Thammavongsa, V., O. Schneewind, and D. M. Missiakas. 2011. Enzymatic properties of Staphylococcus aureus adenosine synthase (AdsA). BMC Biochem. 12: 56.
24. Thammavongsa, V., J. W. Kern, D. M. Missiakas, and O. Schneewind. 2009. Staphylococcus aureus synthesizes adenosine to escape host immune responses. J. Exp. Med. 206: 2417-2427.
25. Thammavongsa, V., D. M. Missiakas, and O. Schneewind. 2013. Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death. Science 342: 863-866.
26. Haskó, G., J. Linden, B. Cronstein, and P. Pacher. 2008. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7: 759-770.
27. Serezani, C. H., M. N. Ballinger, D. M. Aronoff, and M. Peters-Golden. 2008. Cyclic AMP: master regulator of innate immune cell function. Am. J. Respir. Cell Mol. Biol. 39: 127-132.
28. Menschikowski, M., A. Hagelgans, H. Kostka, G. Eisenhofer, and G. Siegert. 2008. Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells. Neoplasia 10: 1195-1203.
29. Raymond, B., D. Leduc, L. Ravaux, R. Le Goffic, T. Candela, M. Raymondjean, P. L. Goossens, and L. Touqui. 2007. Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages. PLoS Pathog. 3: e187.
30. Arbibe, L., D. Vial, I. Rosinski-Chupin, N. Havet, M. Huerre, B. B. Vargaftig, and L. Touqui. 1997. Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNFalpha in lipopolysaccharide-induced type II phospholipase A2 synthesis. J. Immunol. 159: 391-400.
31. Raymond, B., L. Ravaux, S. Mémet, Y. Wu, A. Sturny-Leclère, D. Leduc, C. Denoyelle, P. L. Goossens, M. Payá, M. Raymondjean, and L. Touqui. 2010. Anthrax lethal toxin down-regulates type-IIA secreted phospholipase A(2) expression through MAPK/NF-kappaB inactivation. Biochem. Pharmacol. 79: 1149-1155.
32. Antonio, V., A. Brouillet, B. Janvier, C. Monne, G. Bereziat, M. Andreani, and M. Raymondjean. 2002. Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factorkappaB and Ets transcription factors. Biochem. J. 368: 415-424.
33. Park, J. H., Y. G. Kim, C. McDonald, T. D. Kanneganti, M. Hasegawa, M. Body-Malapel, N. Inohara, and G. Núñez. 2007. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178: 2380-2386.
34. Wu, Y. Z., S. Medjane, S. Chabot, F. S. Kubrusly, I. Raw, M. Chignard, and L. Touqui. 2003. Surfactant protein-A and phosphatidylglycerol suppress type IIA phospholipase A2 synthesis via nuclear factor-kappaB. Am. J. Respir. Crit. Care Med. 168: 692-699.
35. Kapetanovic, R., M. Parlato, C. Fitting, V. Quesniaux, J. M. Cavaillon, and M. Adib-Conquy. 2011. Mechanisms of TNF induction by heat-killed Staphylococcus aureus differ upon the origin of mononuclear phagocytes. Am. J. Physiol. Cell Physiol. 300: C850-C859.
36. Grass, D. S., R. H. Felkner, M. Y. Chiang, R. E. Wallace, T. J. Nevalainen, C. F. Bennett, and M. E. Swanson. 1996. Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J. Clin. Invest. 97: 2233-2241.
37. Eerola, L. I., F. Surrel, T. J. Nevalainen, M. H. Gelb, G. Lambeau, and V. J. O. Laine. 2006. Analysis of expression of secreted phospholipases A2 in mouse tissues at protein and mRNA levels. Biochim. Biophys. Acta 1761: 745-756.
38. Touqui, L., M. Paya, F. Thouron, A. Guiyoule, M. L. Zarantonelli, D. Leduc, Y. Wu, M. K. Taha, and J. M. Alonso. 2005. Neisseria meningitidis pili induce type-IIA phospholipase A2 expression in alveolar macrophages. FEBS Lett. 579: 4923-4927.
39. Shimada, T., B. G. Park, A. J. Wolf, C. Brikos, H. S. Goodridge, C. A. Becker, C. N. Reyes, E. A. Miao, A. Aderem, F. Götz, et al. 2010. Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe 7: 38-49.
40. Weingart, C. L., and A. A. Weiss. 2000. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect. Immun. 68: 1735-1739.
41. Yeager, L. A., A. K. Chopra, and J. W. Peterson. 2009. Bacillus anthracis edema toxin suppresses human macrophage phagocytosis and cytoskeletal remodeling via the protein kinase A and exchange protein activated by cyclic AMP pathways. Infect. Immun. 77: 2530-2543.
42. Buenestado, A., S. Grassin Delyle, I. Arnould, F. Besnard, E. Naline, S. Blouquit-Laye, A. Chapelier, J. F. Bellamy, and P. Devillier. 2010. The role of adenosine receptors in regulating production of tumour necrosis factor-alpha and chemokines by human lung macrophages. Br. J. Pharmacol. 159: 1304-1311.
43. Liu, P., Y. Pian, X. Li, R. Liu, W. Xie, C. Zhang, Y. Zheng, Y. Jiang, and Y. Yuan. 2014. Streptococcus suis adenosine synthase functions as an effector in evasion of PMN-mediated innate immunity. J. Infect. Dis. 210: 35-45.
44. Gonzales, J. N., B. Gorshkov, M. N. Varn, M. A. Zemskova, E. A. Zemskov, S. Sridhar, R. Lucas, and A. D. Verin. 2014. Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 306: L497-L507.
45. Ohta, A., and M. Sitkovsky. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920.
46. Takahashi, N., T. Tetsuka, H. Uranishi, and T. Okamoto. 2002. Inhibition of the NF-kappaB transcriptional activity by protein kinase A. Eur. J. Biochem. 269: 4559-4565.
47. Hsu, L. C., S. R. Ali, S. McGillivray, P. H. Tseng, S. Mariathasan, E. W. Humke, L. Eckmann, J. J. Powell, V. Nizet, V. M. Dixit, and M. Karin. 2008. A NOD2- NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl. Acad. Sci. USA 105: 7803-7808.
48. Miller, L. S., R. M. O'Connell, M. A. Gutierrez, E. M. Pietras, A. Shahangian, C. E. Gross, A. Thirumala, A. L. Cheung, G. Cheng, and R. L. Modlin. 2006. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 24: 79-91.
49. Ouyang, X., A. Ghani, A. Malik, T. Wilder, O. R. Colegio, R. A. Flavell, B. N. Cronstein, and W. Z. Mehal. 2013. Adenosine is required for sustained inflammasome activation via the A2A receptor and the HIF-1a pathway. Nat. Commun. 4: 2909.